Nycomed UK Ltd.
Nycomed is a privately owned, global, market-driven pharmaceutical company with a differentiated portfolio of branded medicines in gastroenterology, respiratory, inflammatory diseases, pain, and osteoporosis and tissue management. An extensive range of OTC products completes the portfolio. With turnover of €3.2 billion in 2009, Nycomed is among the 25 largest pharmaceutical companies in the world and the 15th largest provider of over-the-counter medicines.
In the UK, recent years have seen a dramatic shift in the prescribing landscape. Nycomed UK recognises the need to respond to these significant changes and is committed to adapting its business model to allow it to effectively manage customers’ evolving needs. To this end Nycomed UK has recently introduced a revised model that it believes will allow it to flex and adapt to not only the whole system changes laid out in the recently published White Paper, but also the geographical differences that exist within the NHS. The new structure will provide the platform for national strategies to be implemented through the optimisation of regional opportunities by tailoring the amount and type of resource utilised at a local level as appropriate.
| Type: | NORMAL |
| Address: | Three Globeside Business Park, Fieldhouse Lane, Marlow, Buckinghamshire, SL7 1HZ |
| Website: | http://www.nycomed.co.uk |
| Phone: | + 44 (0) 1628 646400 |
| Fax: | + 44 (0) 1628 646401 |
| Email: | medinfo@nycomed.com |